First in Human Study of IBI101 in Chinese Subjects With Advanced Solid Tumors
Clinical trial NCT03758001 · COMPLETED
Trial details
- NCT number
- NCT03758001
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-13
- Primary completion
- 2023-02-16
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.